Serum pepsinogen I and gastrin in peptic ulcer patients using nonsteroidal anti-inflammatory drugs

Hepato-Gastroenterology

Volumn 44, Issue 16, 1997, Pages 1143-1146

  Kemppainen, Helena ^a,b   Räihä, Ismo ^a   Sourander, Leif ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b Dept of Geriatrics ^*  (Finland)

Author keywords

Elderly; Gastrin; Helicobacter pylori; NSAID; Pepsinogen I; Peptic ulcer

Indexed keywords

GASTRIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEPSINOGEN I; PROSTAGLANDIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CELL PROLIFERATION; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA CELL; PEPTIC ULCER; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; STOMACH BIOPSY; STOMACH MUCOSA; STOMACH ULCER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; BIOPSY; FEMALE; GASTRIC MUCOSA; GASTRINS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPSINOGENS; QUESTIONNAIRES; RADIOIMMUNOASSAY; STOMACH ULCER;

EID: 0030849687     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Samloof IM. Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescense. Gastroenterology 1971;61:185-188.
2. Samloff IM, Liebman WM. Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescense. Gastroenterology 1973;65:36-42.
3. Saez-Alquezar A, Marchese MA, Bezerra TVS, Adreoli JC, Parra DC, Pontes JF. Serum pepsinogen: correlation of techniques and analysis of levels found in different diseases of the stomach and duodenum. Clin Chem Acta 1978;9:163-169.
4. Lombarts AJPF, Peters HJ. Routine determinations of serum pepsinogens. Clin Chem Acta 1972;36:195-200.
5. Ippoliti A, Walsh J. Newer concepts in the pathogenesis of peptic ulcer disease. Surg Clin North Am 1976;56:1479-1490.
6. Chittajallu RS, Dorrian CA, Ardill JES, McColl KEL. Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol 1992;27:20-24.
7. Daugherty DF, Lucey MR, Yamada T. Gastric secretion. In: Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE, eds. Textbook of Gastroeneterology. Vol 1. Philadelphia: JB Lippincott Co, 1991:233-264.
8. Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calan J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989;1:1167-1169.
9. Levi S, Dollery CT, Bloom SR, Calam J, Cox TM, Hodgson HJ, Losowsky MS, Pepys MB, Wright NA, Wrong OM. Campylobacter pylori, duodenal ulcer disease, and gastrin. Hypergastrinaemia due to bacterial colonisation responds to antibiotics. BMJ 1989;299:1093-1095.
10. Graham DY, Opekun A, Lew GM, Klein PD, Walsh JH. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Gastroenterology 1991;100:1571-1575.
11. Taha AS, Sturrock RD, Russell RI. Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori. Gut 1995;36:334-336.
12. Fiorucci S, Santucci L, Gresele P, Luinelli O, Morelli A. Effect of NSAIDs on pepsinogen secretion and calcium mobilization in isolated chief cells. Am J Physiol 1995;268:G968-78.
13. Janssen M, Dijkmans BA, Vandenbroucke JP, Biemond I, Lamers CB. The frequency of extermely low serum pepsinogen, indicative of corpus gastritis with severe atrophy, in rheumatoid arthritis, other chronic rheumatic diseases and non-rheumatic diseases. Br J Rheumatol 1993;32:371-374.
14. Misiewicz JJ, Tytgal GNJ, Goodwin CS, Price AB, Sipponen P, Strickland RG, Cheli R. The Sydney System: a new classificationof gastritis. Working Party Reports of the World Congress of Gastroenterology. Oxford: Blackwell Scientific Publications Ltd, 1990;1-10.
15. Varis K, Sipoonen P. Gastritis. In: Gary Gitneck, editor. Principles and Practice of Gastroenterology and Hepatology. 2nd ed. Norwalk, Connecticut: Appleton & Lange, 1994;185-197.
16. Santucci L, Fiorucci S, Patoia L, Di-Matteo FM, Brunori PM, Morelli A. Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens. Dig Dis Sci 1995;40:2074-2080.
17. Shallcross TM, Rathbone BJ, Wyatt JI, Heatly RV. Helicobacter pylori associated chronic gastritis and peptic ulceration in patients taking non-steroidal anti-inflammatory drugs. Aliment Pharmacol Therap 1990;4:515-522.
18. Lanza FL, Royer GL, Nelson RS, Chen TT, Seckman CE, Rack MF. The effect of ibuprofen, indomethacin, aspirin, naproxen and placebo on the gastric mucosa of normal volunteers: a gastroscopic and photographic study. Dig Dis Sci 1979;24:823-828.
19. Moilanen E, Kankaanranta H. Tolfenamic acid and leukotriene synthesis inhibition. Pharmacol Toxicol 1994;75 [Suppl 2]:60-63.
20. Levi S, Goodlad RA, Lee CY, Stamp G, Walport MJ, Wright NA, Hodgson HJF. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990; 336:840-843.